Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded
- Contract number
- SPE2DX25F6RZS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $35,404
Award facts
- Contract value 100% obligated
- $35,404.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Gamunex-C (immune globulin intravenous human 10% solution), a specialized immunoglobulin therapy product in 20 gram/200 milliliter vials. This firm fixed-price delivery order, valued at $35,404.20, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with a completion date of August 11, 2025. The award is structured as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical prime vendor agreement extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, leverages its broad portfolio of brand-name and generic medications to support Defense Health Agency requirements and other military healthcare systems worldwide. The company's extensive track record with competitively awarded delivery orders across multiple therapeutic domains—including immunological, neurological, and pain management products—demonstrates its capability to fulfill specialized medical procurement needs. This delivery order exemplifies the company's operational flexibility within the DLA Troop Support Medical prime vendor framework, enabling rapid response to specific immunoglobulin therapy requirements across the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6RZS?
SPE2DX25F6RZS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6RZS worth?
The government has obligated $35,404 on SPE2DX25F6RZS.
Is contract SPE2DX25F6RZS an order under another contract?
Yes. SPE2DX25F6RZS is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6RZS competed?
The extent of competition for SPE2DX25F6RZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award